For investors in Singapore

Global Life Sciences Fund

By understanding the science and business of health care, the strategy invests in companies addressing unmet medical needs or improving health care efficiencies

ISIN
IE00B2B36J28

NAV
USD 19.79
As of 2023/09/22

1-Day Change
USD -0.06 (-0.30%)
As of 2023/09/22

Morningstar Rating

As of 2023/08/31

Overview

OBJECTIVE AND INVESTMENT POLICY

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.

Note: You should not make investment decisions based solely on marketing materials. You should read the Prospectus and the Product Highlights Sheet of the Fund for more details of the investment risks and seek independent professional advice where appropriate.

ABOUT THIS FUND

  • Looks to invest in companies addressing unmet medical needs or making the health care system more efficient
  • Aims to maintain a balanced portfolio across subsectors (pharmaceuticals, biotechnology, health care services, and medical devices)
  • An experienced team of specialists that seeks to understand the science and the business of health care

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst

Industry since 2000. Joined Firm in 2000.

Performance

Cumulative & Annualised Performance (%)
As of 2023/08/31
I1 USD (Net) I1 USD (With Sales Charge)* MSCI World Health Care NR
 
  Cumulative Annualised
1MO 3MO 6MO YTD 1YR 3YR 5YR 10YR Since Inception
2016/12/09
I1 USD (Net) -1.44 2.49 6.70 2.44 13.04 5.59 7.64 - 11.31
I1 USD (With Sales Charge)* -3.41 0.44 4.56 0.39 10.78 4.87 7.21 - 10.97
MSCI World Health Care NR -0.77 3.71 6.29 1.30 10.09 6.55 8.22 - 10.85
Calendar Year Returns (%)
As of 2023/06/30
I1 USD (Net) MSCI World Health Care NR
2022 2021 2020 2019 2018
I1 USD (Net) -3.60 5.58 24.35 28.03 2.82
MSCI World Health Care NR -5.41 19.80 13.52 23.24 2.51
FEE INFORMATION
Initial Charge 2.00%
Annual Charge 1.50%
Ongoing Charge
(As of 2023/06/30)
1.57%

Portfolio

Top Holdings (As of 2023/08/31)
% OF FUND
UnitedHealth Group Inc 6.09
Eli Lilly & Co 4.77
AstraZeneca PLC 3.93
Novo Nordisk A/S 3.58
Sanofi 2.94
Merck & Co Inc 2.83
Abbott Laboratories 2.63
AbbVie Inc 2.47
Sarepta Therapeutics Inc 2.44
Thermo Fisher Scientific Inc 2.43
Total 34.11
Sector Allocation % OF FUND % OF FUND (As of 2023/08/31)
Regional Allocation % OF FUND % OF FUND (As of August 31, 2023)

Documents